4 Largecap Quarterly Profit Growing Faster Than Sales Stocks to Watch for Future Multibagger Potential: ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite
- October 29, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
ICICI Bank Rs 1,377.60. Bajaj Finance Rs 917.25. Sun Pharma Rs 1,757.50. Pidilite Rs 1,389.60. Market caps from Rs 1.44 lakh crore to Rs 9.47 lakh crore. Data as of 28 Oct 2026.
Quick Answer
ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite are the 4 picks in this quarterly profit growing faster than sales stocks watchlist, with market caps between Rs 1.44 lakh crore and Rs 9.47 lakh crore. ICICI Bank stands out for the lowest PE of the group at 15.85, while Bajaj Finance offers 19.09% revenue growth in FY26. PE ratios run from 15.85 to 53.72, so compare each one with its industry PE before investing. All figures are as of 28 October 2026.
Quarterly profit growing faster than sales stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite meet that test, with market caps from Rs 1.44 lakh crore to Rs 9.47 lakh crore and ICICI Bank offering the lowest PE of the group at 15.85. Each of these companies has latest quarter net profit growth that is clearly faster than the growth in quarterly sales, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with latest quarter net profit growth that is clearly faster than the growth in quarterly sales, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening quarterly profit growing faster than sales stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 28 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Quarterly Profit Growing Faster Than Sales Stocks and Why Do They Attract Multibagger Interest?
Quarterly profit growing faster than sales stocks are shares of large companies whose net profit grew at a clearly faster pace than their sales in the latest quarter, a sign that costs are well managed and margins are widening. The four here cover private banking, non-banking finance, pharmaceuticals and adhesives.
Profit that rises faster than sales in the most recent quarter shows that the business is becoming more efficient right now, which often shows up in the share price in the quarters that follow. For quarterly profit growing faster than sales stocks, both FY26 and the latest quarter showed growth. Whichever way you read quarterly profit growing faster than sales stocks, the common thread is rising profit backed by complete financial data. With quarterly profit growing faster than sales stocks, comparing valuation, growth and balance sheet strength together works better than relying on one number. Every company in the table below passed a rising-profit check, and the figures for quarterly profit growing faster than sales stocks are complete. Read each company’s latest results and exchange filings before acting on quarterly profit growing faster than sales stocks.
Quarterly Profit Growing Faster Than Sales Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 28 October 2026. ICICI Bank has the lowest PE of the group at 15.85, while Pidilite posts the highest return on equity at 22.61%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| ICICI Bank | 1,377.60 | 9,47,147 | 15.85 | 12.05 | 15.00% | 2.53 | 1,187.60 to 1,480.00 |
| Bajaj Finance | 917.25 | 5,87,079 | 28.44 | 17.68 | 16.68% | 5.15 | 787.90 to 1,176.40 |
| Sun Pharmaceutical Industries | 1,757.50 | 4,22,307 | 34.85 | 36.42 | 13.74% | 5.05 | 1,583.70 to 2,046.90 |
| Pidilite Industries | 1,389.60 | 1,43,732 | 53.72 | 36.15 | 22.61% | 13.27 | 1,259.00 to 1,707.50 |
ICICI Bank: 22.29% Profit CAGR Since FY22
ICICI Bank is one of the largest private sector banks in India, with a strong retail and digital franchise. It reported FY26 total income of Rs 3,12,118.36 crore, up 5.95% year on year, and net profit of Rs 57,673.39 crore, up 5.98%. Net profit has compounded at 22.29% a year since FY22, while total income has grown 18.64% a year.
In the June 2026 quarter, total income rose 6.86% to Rs 79,689.22 crore and net profit grew 12.62% to Rs 16,209.74 crore. The share price has gained 85.57% over five years. Foreign investors raised their holding from 45.56% in September 2025 to 50.44% in September 2026. The stock trades at a PE of 15.85 against an industry PE of 12.05, with a return on equity of 15.00%.
Bajaj Finance: 28.78% Profit CAGR Since FY22
Bajaj Finance is a large NBFC offering consumer, SME, commercial and mortgage loans along with deposits and payment services. It reported FY26 total income of Rs 81,989.50 crore, up 19.09% year on year, and net profit of Rs 19,332.36 crore, up 15.21%. Net profit has compounded at 28.78% a year since FY22, while total income has grown 26.88% a year.
The stock trades at a PE of 28.44 against an industry PE of 17.68, with a return on equity of 16.68%. In the June 2026 quarter, total income rose 18.63% to Rs 23,166.42 crore and net profit grew 27.60% to Rs 6,080.60 crore. Domestic institutions raised their holding from 14.47% in September 2025 to 17.05% in September 2026.
Sun Pharma: 35.75% Profit CAGR Since FY22
Sun Pharmaceutical Industries is one of India’s largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.85 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.
Pidilite: Return on Equity of 22.61%
Pidilite Industries makes Fevicol, Dr. Fixit and other adhesives and construction chemicals. It reported FY26 revenue of Rs 14,867.01 crore, up 11.05% year on year, and net profit of Rs 2,470.72 crore, up 17.87%. Net profit has compounded at 19.62% a year since FY22, while revenue has grown 10.54% a year. Operating margin was 25.81% in FY26. The debt-to-equity ratio is 0.04, which keeps interest costs low.
The stock trades at a PE of 53.72 against an industry PE of 36.15, with a return on equity of 22.61%. In the June 2026 quarter, revenue rose 20.96% to Rs 4,643.55 crore and net profit grew 30.29% to Rs 883.51 crore. Domestic institutions raised their holding from 9.15% in June 2025 to 9.88% in June 2026.
Quarterly Profit Growing Faster Than Sales Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these quarterly profit growing faster than sales stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Total Income (Rs Cr) | Net Profit (Rs Cr) | Income Growth (YoY) | 4-Year Income CAGR | 4-Year Net Profit CAGR |
|---|---|---|---|---|---|
| ICICI Bank | 3,12,118.36 | 57,673.39 | 5.95% | 18.64% | 22.29% |
| Bajaj Finance | 81,989.50 | 19,332.36 | 19.09% | 26.88% | 28.78% |
| Sun Pharma | 61,673.94 | 11,564.52 | 12.69% | 11.62% | 35.75% |
| Pidilite | 14,867.01 | 2,470.72 | 11.05% | 10.54% | 19.62% |
Check the Univest Screener for live data on these quarterly profit growing faster than sales stocks
Institutional Holding in ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite
Institutional holding shows who is backing these quarterly profit growing faster than sales stocks alongside the promoter. The table uses the latest reported quarter for each. ICICI Bank has the deepest institutional backing, with FII and DII together holding 92.22% as of September 2026. Domestic institutions increased their holding over the past year in Bajaj Finance (from 14.47% to 17.05%), Sun Pharma (from 20.23% to 22.27%) and Pidilite (from 9.15% to 9.88%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| ICICI Bank | Nil | 50.44% | 41.78% | 7.78% | September 2026 |
| Bajaj Finance | 54.67% | 19.79% | 17.05% | 8.49% | September 2026 |
| Sun Pharma | 52.68% | 14.36% | 22.27% | 10.70% | September 2026 |
| Pidilite | 69.24% | 11.69% | 9.88% | 9.18% | June 2026 |
Risks to Weigh in Quarterly Profit Growing Faster Than Sales Stocks
Being careful with quarterly profit growing faster than sales stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Bajaj Finance trades at a PE of 28.44 against an industry PE of 17.68, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Quarterly Profit Growing Faster Than Sales Stocks
Picking from quarterly profit growing faster than sales stocks comes down to four checks, applied in order.
- Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
- Compare each PE with the industry PE (12.05 to 36.42) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite live prices.
Conclusion
Among quarterly profit growing faster than sales stocks, ICICI Bank stands out for the lowest PE of the group at 15.85, Bajaj Finance for 19.09% revenue growth in FY26, Sun Pharma for the fastest profit growth, 35.75% a year since FY22 and Pidilite for the highest return on equity at 22.61%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing quarterly profit growing faster than sales stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Quarterly Profit Growing Faster Than Sales Stocks to Watch
Which are the best quarterly profit growing faster than sales stocks to watch for multibagger potential?
Ans. ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite are the 4 names this list highlights, with market caps of Rs 9,47,147 crore, Rs 5,87,079 crore, Rs 4,22,307 crore and Rs 1,43,732 crore respectively. ICICI Bank is notable for the lowest PE of the group at 15.85. Bajaj Finance stands out for 19.09% revenue growth in FY26. Sun Pharma offers the fastest profit growth, 35.75% a year since FY22. Pidilite brings the highest return on equity at 22.61%. These are watchlist names for quarterly profit growing faster than sales stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Pidilite a good stock for long-term investors?
Ans. Pidilite has a return on equity of 22.61%, a PE of 53.72 against an industry PE of 36.15 and a market cap of Rs 1,43,732 crore. Net profit has compounded at 19.62% a year since FY22, and FY26 revenue rose 11.05% while June 2026 quarter net profit grew 30.29%. Long-term returns in quarterly profit growing faster than sales stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Sun Pharma become a multibagger from here?
Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in quarterly profit growing faster than sales stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.85 against an industry PE of 36.42, valuation should be checked against that growth before investing.
What is the market cap of ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite?
Ans. As of 28 October 2026, ICICI Bank has a market cap of Rs 9,47,147 crore, Bajaj Finance has a market cap of Rs 5,87,079 crore, Sun Pharma has a market cap of Rs 4,22,307 crore and Pidilite has a market cap of Rs 1,43,732 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on quarterly profit growing faster than sales stocks.
What are the risks of investing in quarterly profit growing faster than sales stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Bajaj Finance trades at a PE of 28.44 against an industry PE of 17.68, so earnings growth needs to hold up.
Why is Bajaj Finance trading at a PE of 28.44?
Ans. Bajaj Finance’s PE of 28.44 compares with an industry PE of 17.68. The market is paying a premium for a return on equity of 16.68%, profit growth of 28.78% a year since FY22 and latest-quarter profit growth of 27.60%, which also means the stock is more sensitive if growth slows. Investors in quarterly profit growing faster than sales stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in ICICI Bank, Bajaj Finance, Sun Pharma and Pidilite?
Ans. As of the latest reported quarter, FII and DII together hold 92.22% of ICICI Bank (50.44% and 41.78%), 36.84% of Bajaj Finance (19.79% and 17.05%), 36.63% of Sun Pharma (14.36% and 22.27%) and 21.57% of Pidilite (11.69% and 9.88%). Rising institutional holding is a useful signal in quarterly profit growing faster than sales stocks, though it should be read with earnings trends rather than on its own.
